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ABSTRACT
The laboratory mouse is the premier animal model
for studying human disease and thousands of
mutants have been identified or produced, most
recently through gene-specific mutagenesis
approaches. High throughput strategies by the
International Knockout Mouse Consortium (IKMC)
are producing mutants for all protein coding
genes. Generating a knock-out line involves huge
monetary and time costs so capture of both the
data describing each mutant alongside archiving
of the line for distribution to future researchers
is critical. The European Mouse Mutant Archive
(EMMA) is a leading international network infras-
tructure for archiving and worldwide provision of
mouse mutant strains. It operates in collaboration
with the other members of the Federation of
International Mouse Resources (FIMRe), EMMA
being the European component. Additionally
EMMA is one of four repositories involved in the
IKMC, and therefore the current figure of 1700
archived lines will rise markedly. The EMMA
database gathers and curates extensive data on
each line and presents it through a user-friendly
website. A BioMart interface allows advanced
searching including integrated querying with other
resources e.g. Ensembl. Other resources are able to
display EMMA data by accessing our Distributed
Annotation System server. EMMA database access
is publicly available at http://www.emmanet.org.
INTRODUCTION
The laboratory mouse has emerged as the major mamma-
lian model for studying human genetic and multi-factorial
diseases. Numerous mouse mutants have been produced
and, more recently, technological improvements have
allowed mouse mutants for virtually any gene to be pro-
duced by gene-speciﬁc approaches (knock-outs, knock-ins
and conditional mutagenesis). Random approaches such
as large scale, genome-wide ENU mutagenesis and gene
trapping have also expanded the current repertoire
of available mutants. Using these mouse mutants,
researchers are able to decipher molecular disease and
potentially develop new diagnostic, prognostic and thera-
peutic approaches.
The International Knockout Mouse Consortium
[IKMC (http://www.knockoutmouse.org); (1,2)] is made
up of four major projects (EUCOMM (http://www
.eucomm.org) in Europe, KOMP (http://www.nih
.gov/science/models/mouse/knockout/) and TIGM
(http://www.tigm.org) in the USA and NorCOMM
(http://www.norcomm.org) in Canada, and is in the
process of producing mutations in ES cells for all known
protein coding genes. A number of mouse mutant lines
have already been produced from these resources. In
particular, some 650 mouse lines are being produced and
phenotyped in high-throughput screens as part of the
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.eumodic.org), the results of which will be presented in
the Europhenome resource (3). To take this process to
the next level, the International Mouse Phenotyping
Consortium (IMPC) has recently been formed with a
remit to raise the funding for and to coordinate the pro-
duction of mouse mutants for each of the IKMC
mutations, along with high throughput phenotyping of
these mice resulting in the ﬁrst complete catalogue of
mammalian gene function (see Appendix 6 of the
PRIME ﬁnal report: http://www.prime-eu.org/PRIME
ﬁnal report.pdf).
Archiving and distribution of the products of these
various projects is a vital activity, alongside the capture
of data describing in detail the genotype and phenotype
characteristics of the mutants. The costs for a typical
academic researcher to regenerate from scratch one
of these knock-out (KO) lines has been estimated at
E25–30k and would take at least 9 months. Regenerating
the mouse lines is an obvious waste of public funds for
science as well as laboratory mice from an animal welfare
aspect.
Since no single archiving facility can retain all of these
mutant mouse strains it is essential that all mutants that
have been created are held in centrally organised reposi-
tories, from which mutant mice can readily be made avail-
able to interested investigators (4,5). The European Mouse
Mutant Archive [(EMMA); (6)] is a leading international
network infrastructure for archiving and provision of
mouse mutant strains for the whole of Europe and world-
wide. To provide the best possible service to the interna-
tional scientiﬁc community there is a requirement for
coordination of archiving and distribution of the
valuable genetically deﬁned mice and ES cells in line with
global research demand. The Federation of International
Mouse Resources [(FIMRe); (7)], of which EMMA is a
founding member and the European component, was
initiated in response to this need for coordination.
As well as coordination of archiving, there is a require-
ment for a common portal that allows searching of all
publicly available mice, including those not from FIMRe
partners, followed by redirection to individual repositories
for more detailed information and the possibility to order
material. The International Mouse Strain Resource
[IMSR (http://www.ﬁndmice.org); (8)] has been developed
to fulﬁll this need and over the last few years, EMMA has
become one of the largest mouse network repositories
worldwide and a major contributor to IMSR.
EMMA also has a special role in the archiving and dis-
tribution of mouse mutants as it is one of four repositories
handling the mouse resources produced by the IKMC
initiative (EMMA archiving and distributing the
mutant mice arising out of the EUCOMM project, the
KOMP repository (http://www.komp.org) handling
KOMP products, the Canadian Mouse Mutant
Repository [CMMR (http://www.cmmr.ca); (9)] handling
the NorCOMM resources and TIGM handling its own
products. Eventually, these four resources will provide
access to data and material covering the complete, func-
tional characterised, proteome of the mouse, providing an
unprecedented resource for bench scientists studying all
aspects of the mammalian genome including human
disease.
The EMMA resource database described in this paper
provides up to date information about the archiving
status of mice and describes the genetic and phenotypic
properties of all the mutant strains that EMMA stocks.
The EMMA database has two main beneﬁts to the
research community: (i) scientists with particular gene or
genes of interest can discover if any mouse lines exist with
mutations in these gene(s) and what the observed
phenotype changes were, which may provide clues to the
gene’s role, and (ii) it allows scientists to order existing
mouse mutants for further research and generation of
data of interest to other researchers. As well as providing
user-friendly searching and browsing of the database, the
EMMA website is the link to the scientiﬁc community
and facilitates the submission of mice to the EMMA
and requests of mice from EMMA, as well as expressing
interest in strains currently undergoing archiving. The
data recorded for each strain is a combination of
data entered by the original submitting scientist as well
as subsequent curation to correct and add extra value to
the database. Although the full record is only available
through the EMMA database, summary data is
exchanged with our partners in IKMC and the IMSR to
ensure that researchers using the portals available at their
sites see descriptions of EMMA lines, along with links
back to the original record in EMMA and the option to
order biological material. In addition, EMMA utilises the
BioMart data management system (10,11) and the
Distributed Annotation System [DAS; (12)] to allow
distributed, integrated querying with other resources
such as the Ensembl genome browser (13).
DATA COLLECTION AND CURATION
The EMMA website is used to advertise the goals of the
project and encourage interested parties to submit mouse
mutant lines of widespread use to the scientiﬁc research
community as a disease model or other research tool. The
submission process is handled automatically by the
website and collects extensive data through a web form
and stores this directly in the EMMA database. Data col-
lected at this stage includes:
. Contact details for the strain producer.
. Strain name, aﬀected gene(s) and mutant allele(s).
. Genetic background of the original mutation and
current background.
. Genetic and phenotype descriptions of the line.
. Bibliographic data on the line.
. Whether the mouse models a human disease and an
OMIM ID if appropriate.
. Whether the strain is immunocompromised.
. Whether homozygous mice are viable and fertile and if
homozygous mating are required.
Additional optional data collected includes:
. Aﬀected chromosome, dominance pattern and ES cell
line(s) used for targeted mutants.
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. Mutagen used for induced mutant lines.
. Promoter, founder line number and plasmid/construct
name(s) for transgenic lines.
. Breeding history of the line.
. Current health status of the line and speciﬁc informa-
tion for animal husbandry such as diet used.
. How to characterise the line by genotyping,
phenotyping or other methods e.g. coat colour.
. Research areas the mouse is useful for, and whether it
is a research tool such as a Cre-recombinase expressing
line.
Extensive curation takes place to correct and augment
the initial submission data. To facilitate input of correct
data by submitting users, speciﬁc tools have been incor-
porated into the submission form, for searching and
selecting approved gene, allele, background names,
symbols and identiﬁers (from the Mouse Genome
Database (MGD) developed by the Mouse Genome
Informatics (MGI; http://www.informatics.jax.org)
group (14). Similar tools for searching and selecting
PubMed bibliographic references and identiﬁers have
also been implemented. However, there is still a require-
ment for manual correction of submitted data using our
curation interfaces.
The curation is based on the application of interna-
tional rules and standards for the initial assignment
and periodic review and update of the strain and
mutation nomenclature, as deﬁned by the International
Committee on Standardized Genetic Nomenclature for
Mice (http://www.informatics.jax.org/mgihome/nomen).
These approved deﬁnitions make use of control
vocabularies for gene, allele, background names and
symbols. Speciﬁc automated routines and associated
manual curation procedures have been deﬁned and imple-
mented, in particular, for:
. Assigning to each submitted strain record a unique
EMMA identiﬁcation (ID) as the primary attribute
for internal strain identiﬁcation and retrieval and
cross-reference with connected databases such as
IMSR.
. Checking that the submitted records of mutant genes
or expressed transgenes (and corresponding alleles),
carried by the deposited strains, have assigned the
correct names, symbols and identiﬁers, and mutation
classiﬁcation (as deﬁned by MGI) according to the
associated bibliographic references.
. Proposing new mutant gene and allele names,
symbols and identiﬁers for publication in the MGD
database, according to the associated bibliographic
references or personal communication with submitting
scientists.
. Checking that the submitted backgrounds of deposited
strains have approved names and symbols assigned.
. Inserting a preliminary strain designation for each
newly submitted strain, including the assigned strain
background name and the MGI allele symbol,
and associating it with the corresponding EMMA
strain ID.
. Reviewing and approving the preliminary strain
designations, in collaboration with the curation
group at IMSR.
. Periodically reviewing and updating of current strain
designations, according to variations of MGI gene and
allele’s names and symbols.
. Automated correction and population of biblio-
graphic data using the submitted PubMed IDs and
the CiteXplore web service (http://www.ebi.ac
.uk/citexplore/).
Archiving of submitted mice is handled by one of the
EMMA mouse archiving partners (CNR Instituto di
Biologia Cellulare in Monterotondo, Italy; the CNRS
Centre de Distribution de Typage et d’Archivage
Animale in Orleans, France; the MRC Mammalian
Genetics Unit in Harwell, UK; the Karolinska Institute
in Stockholm, Sweden; the Helmholtz Zentrum Mu ¨ nchen
in Munich, Germany; the Wellcome Trust Sanger Institute
in Hinxton; the Institut Clinique de la Souris in
Strasbourg and the CNB-CSIC, Centro Nacional de
Biotecnologia in Madrid). The archiving process
involves genotype and/or phenotype veriﬁcation of the
mouse, followed by test freezing of either sperm or
embryos and then checking the stock can be reconstituted
from this frozen stock. Several strains are in particularly
high demand as they represent extremely interesting
disease models or valuable Cre-expressing lines and these
are kept as live stocks facilitating a fast delivery to the
customers. The EMMA lines are supplied to the
research community for research purposes only and
there is no charge for the cryopreservation service.
Archiving of mice produced by the EUCOMM mouse
production centres follows the same procedure except
the initial import of data describing these lines is
automated from the EUCOMM database. The EMMA
database is used internally by the EMMA partners to
track each mutant strain through the archiving process.
For example, the status of the strain in the archiving
pipeline, which centre is archiving the strain, the funding
source for this archiving, which material is currently in
stock and available to order is all stored in the database.
EMMA archiving centres record this data using internal
interfaces implemented using Java Spring and Hibernate
technologies.
Requests for EMMA mice are also submitted via the
EMMA website and recorded in the EMMA database.
The archiving centres again track the whole process of
distributing the requested mice using the database and
the same internal Java interfaces.
EMMA now contains over 1700 submitted strains from
19 countries including around 50 lines from the USA,
Canada and Australia. In the coming 5 years, it is pre-
dicted that there will be a tripling of the mouse lines held,
largely as a result of the IKMC initiative. To date EMMA
has sent out 1245 lines to requesting scientists worldwide.
Although nearly 58% of the requests for mutant mouse
lines were from European scientists, about one-third come
from the USA and Canada and requests from Asia are
steadily increasing. So far, EMMA has shipped mice to
scientists from more than 500 diﬀerent institutions located
D572 Nucleic AcidsResearch, 2010, Vol.38,Database issuein 39 countries. Considering the estimated cost of gene-
rating these lines from scratch the existence of the EMMA
resource has saved the worldwide community E37M
and 934 years of laboratory eﬀort.
QUERYING THE EMMA DATABASE
The EMMA database can be searched using a user-
friendly query interface (Figure 1). This search takes
full/partial case-insensitive terms and searches against
the oﬃcial MGI gene symbols e.g. Otog, the oﬃcial
IMSR designated strain name e.g. B6.129S2-Otog
tm1Prs/
Orl, the common strain name e.g. OtogC57BL/6J, the
phenotype description e.g. auditory functions or EMMA
IDs e.g. EM:01820. EMMA lines are also browsable by
the aﬀected gene, mutant type (e.g. Targeted Knock-out,
Targeted Knock-in), particular research tools (e.g.
Cre-expressing lines) or mice produced by large projects
(e.g. EUCOMM lines). Results of searches or browsing
are presented in a table, sortable by any of the columns,
which lists the EMMA ID, gene aﬀected (with hyperlinks
back to MGI pages describing the particular gene and
mutant alleles in detail), common strain name, approved
international name and a link to either order the line or
express interest in ordering lines that are in the process of
being archived. The latter option triggers an automated
process, in which the particular archiving centre is
informed that there is a priority for this line and when it
becomes available further automated emails inform the
original scientist that they can go ahead and complete
the ordering process.
Clicking on any of the strain names pops up a strain
description (Figure 2) including the mutation type, genetic
background it is currently maintained on, genetic and
phenotype descriptions if known, the original producer,
literature references, the genotyping or phenotyping
protocol needed to conﬁrm the mutation, what material
is available along with delivery times and costs and a link
for downloading associated Material Transfer Agreement
(MTA) documentation, if applicable.
INTEGRATION WITH OTHER RESOURCES
As described earlier, a subset of data on each of the
EMMA curated lines are sent weekly to the IMSR,
allowing users searching this common catalogue of
mutant lines to be redirected to our site for more detailed
data and the ability to order the line. The MGD database
Figure 1. Browsing and searching for mouse lines in EMMA. Relevant strains can be identiﬁed by either (i) typing case-insensitive, full/partial terms
in the top text ﬁeld which searches against the aﬀected gene symbols and name, approved international designated and common strain names,
phenotype description and EMMA ID, or (ii) browsing through a complete list of lines or partial lists categorised by the aﬀected gene(s), mutant
type (targeted, gene trap, transgenic, induced, chromosomal anomalies or spontaneous), research tool [Cre recombinase expressing strains, lines for
tetracycline (Tet)-regulated gene expression systems], strains provided by the Wellcome Trust Knockout Mouse Resource and ﬁnally strains produced
out of the EUCOMM programme. Results are presented as a table of the EMMA ID, aﬀected gene, common and approved international strain
names alongside links to order or register interest in ordering a line when it becomes available. Clicking on any of the common strain names pops up
a description of the strain.
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and EMMA links to the MGD pages, wherever possible
as the deﬁnitive source for this data.
As well as our simple search box, we also provide an
advanced BioMart query interface, which is linked from
the main search page (Figure 3). The BioMart interface
queries a denormalised snapshot of the EMMA database
that is updated nightly. Queries can involve complex
combinations of query terms including the aﬀected
gene symbols and MGI IDs, common and oﬃcial strain
names, EMMA IDs, mutant type, original and maintained
genetic backgrounds and the type of material available
(frozen embryos, sperm or ovaries, live mice on shelf or
mice rederived from frozen stock). The results are fully
conﬁgurable, allowing any combination of the ﬁelds
presented in the standard EMMA search results and
strain descriptions to be displayed, as well as extra data
such as whether the mutant is viable and fertile when
homozygous and whether it is required to keep it
homozygous, whether the line is immunocompromised,
if it represents a human model, the breeding history and
for targeted mutants known dominance and ES cell line
used, and for transgenics the promoter and plasmid con-
struct used. The results can be previewed and exported
in a number of formats such as HTML, Tab/Comma-
separated text or Excel. However, the real beneﬁt of
BioMart comes from the ability to perform integrated
querying with BioMarts deployed on other resources,
which share a common identiﬁer such as MGI or
Ensembl IDs. For example, in Figure 3a BioMart query
Figure 2. EMMA strain descriptions. Data presented includes the mutation type, genetic background it is currently maintained on, brief genetic and
phenotype descriptions if known, the original producer, literature references, the genotyping protocol needed to conﬁrm the mutation, what material
is available along with delivery times and costs and a link for downloading associated MTA documentation, if applicable.
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aﬀected gene annotated by Ensembl as being located
on the ﬁrst 100Mbp of chromosome 1 and having a
transmembrane protein domain.
A new portal is currently being developed for the IKMC
initiative by the International-Data Coordination Center
(I-DCC; http://www.i-dcc.org). This will be released late
2009 and will display the status of all genes in the
mutagenesis pipeline along with available products and
data for the mutant ES cells and mouse lines. The portal
will utilise a number of BioMarts developed for the IKMC
component mutagenesis pipelines and repositories, as well
as for other useful resources such as the GXD (15) and
Eurexpress (http://www.eurexpress.org) gene expression
databases, and the Europhenome phenotyping resource.
The EMMA BioMart will form an integral component
of this IKMC portal and in addition allow a wider
variety of integrated queries from our EMMA BioMart
server.
Another type of data integration is provided by
our Distributed Annotation System (DAS) server
(www.emmanet.org/das). This serves up summary level
data for each EMMA line, allowing the display of
EMMA strains on DAS clients such as the Ensembl
genome browser. For example by browsing to
http://www.ensembl.org/Mus_musculus/Gene/External
Data/EMMA?g=ENSMUSG00000055694 and clicking
on the ‘Conﬁgure this page’ option and selecting
EMMA it is possible to view any EMMA lines that exist
for this gene (Gdf1). The EMMA ID, aﬀected gene
symbol, name and link to curated data at MGI is given
along with the mutation type, phenotype summary and a
link to the strain description at EMMA.
CONCLUSION AND FUTURE DIRECTION
The number of mutant mouse lines submitted to EMMA
as well as the number of requests for these mutants is
likely to increase signiﬁcantly in the near future. This is
due to the large scale and systematic eﬀorts of the IKMC
to perform saturation mutagenesis of the mouse genome
using gene targeting and gene trapping approaches. As
well as continuing to expand the number of lines curated
and distributed by the EMMA resource, collaboration
with international eﬀorts to present all available mutants
worldwide is going to become ever critical as the IKMC
and eventually the IMPC initiatives continue to produce
and characterise mutants. Data exchange with IMSR will
continue to provide a common access site and EMMA will
collaborate extensively with the I-DCC to provide a
central portal to the data and products produced by the
IKMC. There will be a particular focus on utilising the
phenotyping data arising out of these programmes to
allow searching for mouse models using precise phenotype
queries structured using the Mammalian Phenotype (MP)
ontology (16).
The EMMA project is currently funded until 2013, but
obviously long term, stable funding for the data storage
and mouse archiving that EMMA performs will be critical
to capture and maintain the products emerging from the
IKMC and IMPC programmes. This is a recognised issue
and the European Commission is currently funding
a number of projects under the ESFRI Roadmap with
the goal of identifying sources of long term funding
for key scientiﬁc activities. Infrafrontier (http://www
.infrafrontier.eu) is one of these projects and is tasked
with securing such funding for archiving and phenotyping
of mouse mutants. Infrafrontier has already decided that
the archiving aspect will be taken care of by a major
upgrade to the EMMA project. Hence, it is highly likely
that EMMA will continue providing this valuable service
to the worldwide scientiﬁc community for many years
to come.
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